Non-hormone medication addresses menopausal symptoms in women

The first real-world study of the FDA-approved nonhormone treatment fezolinetant found the menopausal medication improved hot flashes, depression and anxiety in women, according to industry-sponsored research presented at ...

Type 1 diabetes diagnoses surge among Puerto Rican teens

The incidence of type 1 diabetes among teens in Puerto Rico more than doubled from 2009 to 2021 and remained elevated through 2024, with an average annual increase of 4.1%, according to a study presented at ENDO 2026, the ...

page 6 from 40